Entera Bio Ltd
Entera Bio Ltd (ENTX) Option Chain
As of September 16, 2026, Entera Bio Ltd is trading at $2.96, a +3.50% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 393.3%. IV Rank is 36%.
Read more
Tracking the ENTX option chain helps you see every strike and expiry on Entera Bio Ltd in one view, so you can quickly identify the contracts that fit your thesis and your risk. Entera Bio Ltd's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ENTX options activity at a glance. Use our scanner to monitor the ENTX option chain in real time and filter for the ENTX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ENTX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ENTX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ENTX stock options are being actively traded and where they are not.
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses.
Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Entera Bio Ltd's full chain across every expiry, highlights the most liquid strikes, and lets you screen ENTX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ENTX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile41.67% Neutral
- Market cap (M$)515
- 52 weeks high-29.52%
- 52 weeks low225.27%
- Analyst recommendationStrong Buy
1.00 - Target price$9.00
204.05% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-13
- P/E—
- Future P/E—
- EPS (ttm)-0.35
- EPS growth next 5 years—
As of September 16, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 0 | 0 | 2.34 | 1.96 | — | 4.30 | 1.00 | -64.79 | — | 2.55 | 0.00 | 2.55 | 0 | 0 | 100.00 |
| 0.97 | 0 | 0 | 2.54 | 0.96 | — | 3.50 | 2.00 | -29.58 | — | 0.10 | 0.00 | 0.10 | 0 | 0 | 99.03 |
| 67.14 | 11 | 0 | 2.65 | 0.00 | — | 2.65 | 3.00 | +5.63 | 0.10 | 0.40 | 0.04 | 0.21 | 0 | 1,415 | 32.86 |
| 99.22 | 412 | 0 | 2.55 | 0.00 | — | 2.55 | 4.00 | +40.85 | — | 3.70 | 1.04 | 2.66 | 0 | 0 | 0.78 |
| 100.00 | 6 | 0 | 2.55 | 0.00 | — | 2.55 | 5.00 | +76.06 | — | 4.70 | 2.04 | 2.66 | 0 | 0 | 0.00 |
As of September 16, 2026
Scan the full option chain in one place
Browse the full ENTX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→